Cypre's blog to discuss the latest movements in science.
Charles River’s Oncology Therapeutic leader, Julia Schüler, writes about the impact of the Cypre 3D tumor platform in assaying the tumor microenvironment, stating ”We now have a platform for robust and repeatable screening using high-content image analysis. The hope is that this will rapidly identify a pipeline of effective therapies that hold up in the clinic and make it to patients.”
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
